Clinical Guidance

AGA updates MASLD care pathway

• by Doug Brunk

A two-tier strategy is recommended using noninvasive tests to identify patients who require specialty evaluation.

Therapeutic endoscopy expands in IBD

• by Doug Brunk

AGA update outlines when advanced endoscopic interventions can delay or prevent surgery and how to select patients most likely to benefit.

Genetic risk tied to IBD severity

• by Doug Brunk

Large cohort links higher polygenic risk scores to worse outcomes, including surgery and intensive treatment.

Hospital care for IBD gets practical refresh

• by Doug Brunk

“IBD experts around the country are receiving many more calls from community gastroenterologists for advice treating their hospitalized patients,” Dr. Shirley Cohen-Mekelburg said.

ASGE updates guidance on diagnosing and managing GERD

• by Doug Brunk

About one-third of U.S. adults are affected by the condition.

Task force updates ERCP quality metrics

• by Doug Brunk

The indicators are designed primarily for individual endoscopist use but may also support unit- or system-wide initiatives.

Practice update: Refractory constipation

• by Doug Brunk

Longstanding concerns about chronic stimulant laxative use are described as unfounded.

Task force touts greener endoscopy units

• by Doug Brunk

Reducing unnecessary procedures, supplies, and ancillary resources offers the greatest environmental benefit relative to effort.

AGA releases updated guideline on endoscopic surveillance of Barrett’s esophagus

• by Wendy LaGrego

A panel came to a consensus on eight recommendations regarding the role of endoscopic surveillance in patients with Barrett’s esophagus.

GLP-1 receptor agonist use in gastrointestinal endoscopy: A review of current evidence and guidelines

• by Sitharthan Sekar, MD, Nikiya Asamoah, MD

Avoid getting stuck: A practical guide to managing chronic constipation

• by Hamza Salim, DO, Anni Chowdhury, DO, Lavanya Viswanathan, MD, MS

The complexity of this condition should be appreciated and understood in order for a complete and thorough evaluation.

Medical, endoscopic, and surgical management of gastroesophageal reflux disease

• by Patrick Chang, MD, Supisara Tintara, MD, Jennifer Phan, MD

A paradigm shift in evaluating and investigating the etiology of bloating

• by Rajan Singh, PhD, Baharak Moshiree, MD, AGAF

Abdominal bloating is a common condition affecting up to 3.5% of people globally.

GLP-1 receptor agonists in endoscopy

• by GI and Hepatology News

Delivery of care: The ethical imperative in healthcare

• by Aja McCutchen, MD, Mena Boules, MD

Endoscopic management of Barrett’s esophagus

• by Sachin Srinivasan, MD, Prateek Sharma, MD

Celiac disease: Update on diagnosis and monitoring

• by Carol Semrad, MD